Fredrik R. Wermeling
Solna, AB, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 44 publications
Reply to Dnmt3a Loss in T Cells Attenuates Experimental Arthritis: Implications for Interpreting Human CHIP-RA Associations.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: August 11, 2026
Thiol-reactive compound depletion reveals electrophile-dependent and independent anti-inflammatory constituents in Saussurea costus.
Journal: Frontiers in pharmacology
Published: January 24, 2026
Dnmt3a Mutations Limit Normal and Autoreactive CD4+ T Follicular Helper Responses and Attenuate T Cell-Driven Joint Inflammation.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: December 15, 2025
Autoimmunity-associated DIORA1 binds the MRCK family of serine/threonine kinases and controls cell motility.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: October 03, 2025
Bioactivity-guided isolation of anti-inflammatory compounds from the herbs constituting a traditional Chinese medicine formulation used for the treatment of rheumatoid arthritis.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: July 22, 2025
Targeting NFATc1-regulated MTHFD2 one-carbon metabolism to suppress sustained T-cell-mediated inflammation in rheumatoid arthritis.
Journal: Signal transduction and targeted therapy
Published: July 04, 2025
Green Listed v2.0: A Web Application for Streamlined Design of Custom CRISPR Screens.
Journal: The CRISPR journal
Published: May 07, 2025
Noninvasive PET Detection of CD69-Positive Immune Cells Before Signs of Clinical Disease in Inflammatory Arthritis.
Journal: Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Published: July 12, 2023
A genetic-epigenetic interplay at 1q21.1 locus underlies CHD1L-mediated vulnerability to primary progressive multiple sclerosis.
Journal: Nature communications
Published: April 28, 2023
High-content screening of drug combinations of an mPGES-1 inhibitor in multicellular tumor spheroids leads to mechanistic insights into neuroblastoma chemoresistance.
Journal: Molecular oncology
Published: February 21, 2023
Last Updated: 09/26/2026